1933 Industries Inc (TGIFF)
0.0125
0.00 (0.00%)
USD |
OTCM |
Apr 24, 16:00
1933 Industries Cash from Investing (TTM): -0.8835M for Jan. 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
January 31, 2024 | -0.8835M |
October 31, 2023 | -0.8544M |
July 31, 2023 | 1.738M |
April 30, 2023 | 1.300M |
January 31, 2023 | 2.614M |
October 31, 2022 | 2.363M |
July 31, 2022 | 0.0012M |
April 30, 2022 | 0.5924M |
January 31, 2022 | -0.487M |
October 31, 2021 | -0.2757M |
July 31, 2021 | -0.3582M |
April 30, 2021 | 1.102M |
January 31, 2021 | 0.2169M |
October 31, 2020 | -0.8923M |
July 31, 2020 | -0.919M |
April 30, 2020 | -5.207M |
January 31, 2020 | -3.216M |
October 31, 2019 | -6.657M |
July 31, 2019 | -9.574M |
April 30, 2019 | -10.75M |
January 31, 2019 | -14.58M |
October 31, 2018 | -10.49M |
July 31, 2018 | -7.605M |
April 30, 2018 | -6.614M |
January 31, 2018 | -3.884M |
Date | Value |
---|---|
October 31, 2017 | -3.353M |
July 31, 2017 | -3.210M |
April 30, 2017 | |
January 31, 2017 | |
October 31, 2016 | |
July 31, 2016 | |
April 30, 2016 | |
January 31, 2016 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | 0.0003M |
September 30, 2013 | 0.0003M |
June 30, 2013 | -0.0002M |
March 31, 2013 | -0.0005M |
December 31, 2012 | -0.0005M |
September 30, 2012 | 0.0408M |
June 30, 2012 | -0.1044M |
March 31, 2012 | -0.7791M |
December 31, 2011 | -0.7791M |
September 30, 2011 | -0.8224M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-10.75M
Minimum
Apr 2019
2.614M
Maximum
Jan 2023
-1.507M
Average
-0.4226M
Median
Cash from Investing (TTM) Benchmarks
Acasti Pharma Inc | -1.452M |
Aurinia Pharmaceuticals Inc | -6.706M |
Edesa Biotech Inc | 0.00 |
Lexaria Bioscience Corp | -0.1991M |
Xenon Pharmaceuticals Inc | -117.17M |